Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 6
Submit an article Journal homepage
73
Views
10
CrossRef citations to date
0
Altmetric
Review

Chromosome 13 Deletion/Hypodiploidy and Prognosis in Multiple Myeloma Patients

Athanasios B-T Fassas Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 W. Markham St, Little Rock, U.S.A, 72205, USACorrespondence[email protected]
&
Guido Tricot Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 W. Markham St, Little Rock, U.S.A, 72205, USA
Pages 1083-1091 | Received 29 Oct 2003, Published online: 03 Aug 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Robert Z Orlowski & Erik L Zeger. (2006) Targeting the proteasome as a therapeutic strategy against haematological malignancies. Expert Opinion on Investigational Drugs 15:2, pages 117-130.
Read now

Articles from other publishers (9)

Kyle J Thulien, Andrew R Belch, Tony Reiman & Linda M Pilarski. (2012) In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival. Molecular Cancer 11:1.
Crossref
F. Stella, E. Pedrazzini, A. Rodríguez, E. Baialardo, G. Kusminsky, J. Arbelbide, D.B. Fantl & I. Slavutsky. (2011) New Recurrent Chromosome Alterations in Patients with Multiple Myeloma and Plasma Cell Leukemia. Cytogenetic and Genome Research 134:4, pages 249-259.
Crossref
. 2008. Cytogenetics, FISH and Molecular Testing in Hematologic Malignancies. Cytogenetics, FISH and Molecular Testing in Hematologic Malignancies 125 242 .
Esteban Braggio, Michael Sebag & Rafael Fonseca. 2009. Myeloma Therapy. Myeloma Therapy 57 76 .
S Jagannath, P G Richardson, P Sonneveld, M W Schuster, D Irwin, E A Stadtmauer, T Facon, J-L Harousseau, J M Cowan & K C Anderson. (2006) Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials. Leukemia 21:1, pages 151-157.
Crossref
L Chiecchio, R K M Protheroe, A H Ibrahim, K L Cheung, C Rudduck, G P Dagrada, E D Cabanas, T Parker, M Nightingale, A Wechalekar, K H Orchard, C J Harrison, N C P Cross, G J Morgan & F M Ross. (2006) Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia 20:9, pages 1610-1617.
Crossref
Deborah J. Kuhn, Erik L. Zeger & Robert Z. Orlowski. (2006) Proteasome inhibitors and modulators of heat shock protein function. Update on Cancer Therapeutics 1:2, pages 91-116.
Crossref
H. Ludwig. (2005) Advances in biology and treatment of multiple myeloma. Annals of Oncology 16, pages ii106-ii112.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 22:3, pages 135-142.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.